Fact Checked

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles. Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated January 19th, 2023

Hormonal Therapy for Advanced Prostate Cancer

NOW
PLAYING
Steely Eyed TV Host Dan Abrams, 56, Is Now A Dad & Two Decades Past Testicular Cancer – The Hope For Men Facing The Same Disease
NOW
PLAYING
Mom & Nurse, 32, Thought Lump in Breast Was Clogged Milk Duct, But it Was Stage 2 Cancer
NOW
PLAYING
18-Year-Old Didn't Know Teenage Boys Could Get Breast Cancer Until He Found A Growth Above His Nipple
NOW
PLAYING
Rock Band Kiss Co-Founder Peter Criss, 77, Male Breast Cancer Survivor, Releases New Version Of Classic 'Dirty Livin''
NOW
PLAYING
A Father Of Eight Who Never Drank Or Smoked - How He Dealt With The Shock of Cancer at 62
NOW
PLAYING
Newly FDA-Approved Drug Elahere May Be Effective Treatment For Patients With A Particularly Aggressive Form Of Ovarian Cancer

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... prostate cancer trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

Later Stage Treatment: New Treatment Developments

SEE MORE   

  • There are several new drugs and treatment options available for those facing advanced stage prostate cancer.
  • Two PARP inhibitors are currently FDA-approved: Lynparza (olaparib) and Rubraca (rucaparib).
  • Two newer androgen deprivation therapies include: Xtandi (enzalutamide) Erleada (apalutamide).

Later Stage Treatment: New Treatment Developments

  • There are several new drugs and treatment options available for those facing advanced stage prostate cancer.
  • Two PARP inhibitors are currently FDA-approved: Lynparza (olaparib) and Rubraca (rucaparib).
  • Two newer androgen deprivation therapies include: Xtandi (enzalutamide) Erleada (apalutamide).
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.